<DOC>
	<DOC>NCT02733471</DOC>
	<brief_summary>This study evaluates the efficacy and safety of the administration of lidocaine spray in oesophago-gastro-duodenoscopies. Half of the patients will receive lidocaine spray, while the other half will receive a placebo.</brief_summary>
	<brief_title>Evaluation of the Efficacy and Safety of Administering Lidocaine Spray in Oesophago-gastro-duodenoscopy</brief_title>
	<detailed_description />
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Inclusion criteria: Patients aged over 18 ASA I, II and III Non allergic to lidocaine or any of the drugs used in the study Consent form signed by the patient Stomach or esophagus diagnosed cancer Giant hiatal hernia diagnosed Zenker's diverticulum diagnosed Achalasia diagnosed Patients aged over 70 Medical history of moderate to severe liver disease Medical history of moderate to severe renal insufficiency Medical history of moderate to severe Obstructive Sleep Apnea Syndrome (OSA) (AHI≥15). Severe respiratory insufficiency(asmtha or COPD) diagnosed Patients with encephalopaty active Patients with medical history of methemoglobinemia Patients with history of drug abuse Patients with mental impairment Patients with BMI≥ 35 Use of pediatric tube</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Lidocaine</keyword>
	<keyword>Endoscopy</keyword>
	<keyword>Tolerance</keyword>
</DOC>